Glandular kallikrein from salivary glands in rats has been measured in the circulation and has been shown to have local vasoactive effects. In mice, renin and epidermal growth factor from the submandibular gland (SM) also reach the circulation, as both have been measured in plasma. The route by which these peptides enter the blood from their site of synthesis in ducts of the SM is unclear. We have investigated by immunocytochemistry the secretory pathways for kallikrein and renin from salivary duct cells in mice. The renallpanaeatic kallikrein-secreting cells of the striated and exaetory ducts of the SM were distinguished from the granular convoluted tubule (GCT) cells which secrete other glandular kallikreins on the basis of data obtained in previous studies, in which we used gene-specific oligonucleotide probes to identify the expressing cell types. Renal/pancreatic kallikrein was apparently secreted constituUvely from the basolateral surface of striated duct cells and in secretory vesides from excretory duct cells, whereas apical secretion occurred via the regulated pathway in both cell types. Glandular kallikteins and renin synthesized in GCT cells were secreted from the basolateral surface by dissolution of granules at the cell membrane. There were fenestrated capillaries underlying the duct tree which would enable the secreted products to reach the circulation. (JHisrochem Cytochem
Introduction
The glandular kallikrein family of serine protease enzymes is encoded by multiple genes in several mammalian species, including rats, mice, and humans (Riegman et al., 1991; Wines et al., 1991; Evans et al., 1987) . In mice there are 12 highly homologous genes in this family. including the gene designated mGK-6 (van Leeuwen et al., 1986) , which encodes renal/pancreatic or "true" kallikrein, the most highly conserved across species of the glandular kallikreins.
Renallpancreatic kallikrein is involved in the regulation of the local circulation by its enzymic action on a kininogen substrate to generate the peptide vasodilator bradykinin (Kat0 et al., 1985) . Another putative role for this enzyme is in the regulation of transepithelial transport of electrolytes and water, either directly (Lewis and Alles, 1986) or via the action of kinins (Cuthbert and MacVinish, 1986; Schuster et al., 1984) . Renallpancreatic kallikrein is synthesized in renal distal tubules, the exocrine pancreas, and at several other sites, including the ducts of salivary glands.
Autonomic nerve stimulation of salivary secretion in rats causes an increase in the level of glandular kallikrein in plasma and in saliva (Berg et al., 1985; Orstavik et al., 1982) and an increased kinin concentration in the venous effluent of the submandibular gland (Berg et al., 1989) . There is additional evidence to suggest that much of the glandular kallikrein in the circulation of rats originates in the salivary glands (Lawton et al., 198l) , where renallpancreatic kallikrein is synthesized in striated (intralobular) and excretory ducts of the submandibular (SM), sublingual, and parotid glands (Penschow et al., 1991a) . Which of these morphologically and functionally distinct regions of the salivary duct tree secretes the renallpancreatic kallikrein that enters the circulation has not been identified.
The mouse glandular kallikrein genes other than mGK-6 are expressed in the predominant population of granular convoluted tubule (GCT) cells of the SM (Penschow et al., 1991a,b; van Leeuwen et al., 1987) . These cells also synthesize many other peptide hormones, including epidermal growth factor (EGF), nerve growth factor (NGF), and renin (Wilson et al., 1986; Rall et al., 1985; k a k a et al., 1981) , all of which can be released into the circulation (Aloe et al., 1986; %utsumi et al., 1986; Menzie et al., 1974) .
The aim of the present study was to determine by immunocytochemistry the subcellular location of glandular kallikreins and 95 renin synthesized in GCT cells and of renallpancreatic kallikrein synthesized in striated and excretory duct cells. The location of these peptides within cells, in relation to the apical or basolateral cell membrane and adjacent capillaries, may suggest their mode of secretion and the potential routes by which they leave these duct cells and reach the circulation.
Materials and Methods

Tissue Preparation
Adult male and female Swiss mice (n = 4) were anesthetized with Penthrane (Abbott; Sydney, Australia) and perfused via the abdominal aorta with 1% glutaraldehyde (Mer&, Darmstadt, Germany) in 0.1 M phosphate buffer, pH 7.2. Salivary glands and kidneys were excised and dissected into 1-mm strips, which were fixed for a further 18 hr and then dehydrated and embedded in LR White (Bio-Rad; Richmond, CA) by conventional procedures. Semi-thin sections were mounted on slides subbed with 0.1% gela-tinl0.01% chromalum.
Electron Microscopy
Ultra-thin silver-gold sections were mounted on fomvar-coated nickel grids? immunostained as described below, stained with uranyl acetate and alkaline lead citrate, and viewed with a Siemens Elmiskop 102 at 60 kV.
Immunocytochemistry
Antibodies. A polyclonal rabbit antibody to purified mouse a-NGF (kindly provided by Dr. Margaret Fahnestock, Stanford University, Palo Alto, CA) was used for kallikrein immunocytochemistry. a-NGF is one of the mouse glandular kallikrein family of serine protease enzymes (Evans and Richards, 1985) , exhibiting 95% amino acid sequence homology with renallpancreatic kallikrein and a high degree of homology with the other enzymes of the glandular kallikrein family .
The kallikrein antibody showed crossreactivity with renallpancreatic kallikrein, the only glandular kallikrein synthesized in kidney (van Leeuwen et al., 1986) and striated and excretory duct cells of salivary glands (Penschow et al., 1991a; van Leeuwen et al., 1987) . In the mouse kidney, kallikrein immunostaining was confined to the apical portion of cells of distal convoluted and connecting tubules. This distribution ofkallikrein in mouse renal cortex is in agreement with its localization in rat. determined by Simson et al. (1988a,b) with a monoclonal antibody to rat renal kallikrein, and differs from the distribution of esterase A, reported in the same studies.
Because of the extensive amino acid sequence homology between glandular kallikreins, it was not surprising that the antibody to mouse a-NGF detected multiple mouse glandular kallikreins. However, we were able to ascertain from our previous studies (Penschow et al., 1991a.b ) that the kallikrein-immunostained striated and excretory duct cells contained renallpancreatic kallikrein and the predominant GCT cell population contained the other glandular kallikreins (collectively). In those previous studies we used gene-specific oligodeoxyribonucleotide probes to identify which duct cells express specific glandular kallikrein genes ( P e d o w et al., 1991a.b; van Leeuwen et al., 1987) .
As we had no purified renallpancreatic kallikrein for pre-adsorption of the antibody, we were unable to include this type of control. However. a rabbit antibody to mouse renin (kindly provided by Dr. Pierre Corvol, INSERM, Paris) served as a negative control for the renallpancreatic kallikreincontaining population of duct cells while positively immunostaining those GCT cells in which renin was synthesized (Enaka et al., 1981) . As the 11 glandular kallikreins other than renallpancreatic kallikrein are also synthe-sized by the predominant GCT cell population, a comparison of renin and kallikrein secretion from these cells was possible.
An antibody to Factor VI11 was used as an additional negative control (data not shown).
Immunogold and Silver Enhancement. For silver-enhanced immunogold, sections were immunostained by the method of Darby et al. (1990) with a 1:20 dilution of the kallikrein antiserum or 1:50 dilution of the renin and factor VI11 antisera, followed by 1-nm gold-conjugated second antibody (goat anti-rabbit IgG) (Amersham; Poole, UK) at a dilution of 1:50. Silver enhancement was carried out with the Intense kit (Amersham) according to the manufacturer's instructions.
Estimation of Background Levels of Immunostnining. To confirm positive immunostaining of lightly labeled granules shown in electron micrographs, silver-enhanced gold particles were counted over tissue areas and over granules and these areas were analyzed morphometrically using a 5 -m grid. The results were expressed as gold/silver particles per unit area and provided an estimate of background levels of immunostaining over tissue areas relative to levels over granules.
Results
Using gene-specific oligodeoxyribonucleotide probes, we had established previously that the renallpancreatic kallikrein gene mGK-6 was expressed in striated (intralobular) ducts, interlobular excretory ducts, and the main excretory duct of the SM, and that the other 11 glandular kailikrein genes were expressed only in GCT cells (Penschow et al., 1991a,b; van Leeuwen et al., 1987) . In Figures 1 to 4, we show the subcellular location of translation products of mGK-6 and of the other glandular kallikrein genes (collectively) in the various types of SM duct cells, identified by immunocytochemistry.
Striated (Intralobular) Ducts
Striated ducts were more prevalent in the female than in the male SM. Striated duct cells were characterized by their basal "striations" and small apical secretory granules (Tamarin and Sreebny, 1965) ( Figure la) . At the basolateral pole of striated duct cells, kallikrein immunostaining was often present in the cytoplasm between the abundant mitochondria but was not confined to secretory granules ( Figure Ib) . Some immunostaining was on or very close to the basolateral membrane of the cell. This apparent constitutive secretion was evident in a serial section showing the same region of the cell ( Figure IC) and was shown not to be random deposition of silver by the relative absence of staining over mitochondria and extracellular regions (Figures 1b and IC) and by the lack of staining in the control (Figure lf) . Any kallikrein secreted from the basolateral surface of the cells would have been removed during the perfusion fixation, and the absence of immunostaining in the interstitial space was therefore not surprising. Kallikrein immunostaining at the apical pole of the cell was confined to secretory granules ( Figure Id duct and its location can be seen in Figure la in relation to the SD cell described above.
Interlobular Excretory Ducts
The secretory cells of these ducts (Figure 2a ) were characterized by small apical granules. large intercellular spaces, and finger-like basolatcral projections (Tamarin and Srcebny, 1965) . Most of the granules at the apical surface immunostained with the kallikrein antibody (Figure 2a ). whereas none stained with the renin antibody (Figure 2b ). There were also granules present, some of which contained kallikrein. on the basolateral side of the nucleus in association with channels that may provide a route to the cell exterior (Figures 2a, 2c. and 2d) . Collectively. levels of immunostaining over the positive granules indicated in Figures 2c and 2d were 30-60-fold higher than background levels.
Main Excretory Duct
These are the largest of the SM ducts and were easily recognized by their size. the characteristic flattened epithelium (Leeson, 1967) . and the relative lack of apical secretory granules (Figure 3a) . Nevertheless, there were secretory vesicles and occasional small granules at the apical pole of the duct cells, some of which immunostained with the kallikrein antibody ( Figure 3b ) and all of which were negative for the renin control (Figure 3c ). The level of immunostaining over the granule indicated in Figure 3b was 17-fold higher than background levels in Figure 3c . Kallikrein secretion from the basolateral pole of the cell was suggested by an immunostained secretory vesicle which had apparently fused with the basolateral cell membrane (Figure 3d ). Small granules, one of which immunostained for kallikrein, were also present on the basolateral side of the nucleus (Figure 3d ). The level of immunostaining over the granule and vesicle indicated in Figure 3d was 60-fold greater than the background level in Figure 3d .
Grunulur Convoluted Tubules
Granular convoluted tubules were more predominant in male than in female mice and a larger proportion of each GCT cell was occupied by secretory granules in male mice than in females, as previously reported (for review see Chretien, 1977) .
The majority of cells in the GCT contained large electron-dense granules (Figure 4a ) and a minority contained smaller, paler granules (Figure 4d ). Both types of GCTcells contained kallikrein (Figure 4a ) and the predominant type contained renin (Figure 4d ). Those cells with the smaller, paler granules which were positive for kallikrein but negative for renin ( Figure 4d ) correspond to the morphologically distinct subpopulation of cells that express the renallpancreatic kallikrein gene mGK-6 (Penschaw et al., 1991b) . In GCT cells immunostained with either antibody, most of the secretory granules were positive and were usually located near the apical pole of the cell (Figures 4a and 4d) . although in some cells this distribution was not so marked (Figure 4a ). In some of the GCT cells characterized by large apical granules, large and smaller granules that stained with the kallikrein or renin antibodies were also situated near the basolateral pole of the cell (Figures 4b, 4c , 4e, and 4f), sometimes very close to the basolateral membrane (Fig  ure 4b ). There were also localized areas of kallikrein ( Figure 4c ) and renin immunostaining (Figure 4e ) near the basolateral cell membrane which were not confined to secretory granules, suggesting that kallikrein and renin may be secreted into the region of the cell close to the basolateral membrane. The location ofimmunoreactive kallikrein along the basolateral membrane (Figure 4c) and of a renin-containing vesicle fused with the basolateral membrane (Figure 4f ) may indicate secretion of kallikrein and renin into the interstitial space, where there are fenestrated capillaries (Figure 4a ). Figure 4f is six-fold higher than background levels in Figure 4f .
The level of immunostaining over the vesicle in
The antibody to factor VI11 did not label GCT granules or any other component of these cells (data not shown).
Discussion
There is considerable evidence in rats to suggest that proteins synthesized by salivary duct cells can access the circulation. In particular, renallpancreatic kallikrein has been shown to be released from the SM gland into saliva and blood and to mediate the vasoactive effects of kinins on salivary blood flow (Berg et al., 1989) . This release occurs in unstimulated glands and is augmented by a-adrenergic stimulation of the SM gland (Berg et al., 1985; Fbbito et al., 1983) . We have shown in the present study that renal/pancreatic kallikrein may be secreted from both the basolateral and apical surfaces of most of the various types of duct cells that comprise the functionally distinct regions of the salivary duct tree. One observation of considerable interest is that renallpancreatic kallikrein appears to be constitutively secreted from the basolateral surface of striated duct cells, where it can access fenestrated capillaries, while being secreted in granules from the apical surface of the cell by the regulated pathway (Figure 1) . The apparent constitutive secretion would mean that a constant supply of renallpancreatic kallikrein is secreted from the basolateral surface of striated duct cells, which may constitute the "free kallikrein" that is always found in plasma (Berg et al., 1985) . The renallpancreatic kallikrein packaged into secretory granules, which may be secreted from the basolateral surface of interlobular excretory duct cells ( Figure 2 ) and from cells of the main excretory duct (Figure 3) , may be the kallikrein that enters the blood via the regulated pathway after stimulation of the gland (Berg et al., 1985; Orstavik et al., 1982) . The regulated secretory pathway is also the route by which the renal/pancreatic kallikrein in secretory granules (Figures 1 and 2) and in secretory vesicles (Figure 3 ) at the apical surface of duct cells is secreted into the lumen of the duct.
Secretion by constitutive and regulated pathways both occurring in individual cells has been reported for other cell types (for review see Burgess and Kelly, 1987) , including acinar cells of the pancreas (Arvan and Castle, 1987) , which are similar to salivary duct cells in that they also are exocrine cells and one of their secretory products is renaUpancreatic kallikrein.
Esterase A, an esteropeptidase closely related to rat renal kallikrein and with a similar distribution in salivary ducts, has also been located near the basolateral surface of rat submandibular duct cells (Simson et al., 1988b) . The parallel distribution of esterase A and renal kallikrein does not extend to rat kidney (Simson et al., 1988a) , and as our antibody to kallikrein inmunostains regions in kidney corresponding to the distribution of renal kallikrein rather than esterase A, it is unlikely that the immunostaining we have reported in the SM is due to crossreactivity of the kallikrein antibody with esterase A.
Renal/pancreatic kallikrein is synthesized in the salivary glands of most mammals, including humans (Fukushima et al., 1985) , and glandular kallikrein has been measured in human plasma (Mann et al., 1980) . As the structure of striated and excretory ducts in rodents and humans is similar (Tandler, 1963) , it is possible that the glandular kallikrein in human plasma is secreted by cells of striated and excretory ducts in much the same way as in mice (Figures  1-3) . The measurement of urinary kallikrein as a diagnostic indicator of hypertension in humans presumes that the renal distal tubules are the major source of urinary kallikrein. If the salivary glands secrete renal/pancreatic kallikrein into the circulation at high levels in humans, as has been reported in rats (Lawton et al., 1981) , this may account for the variability of urinary kallikrein measurements in hypertensive vs normotensive subjects (Margolius, 1989) .
There is considerable evidence for endocrine effects of peptide growth factors produced by GCT cells of the SM in mice. Some studies show reduced or ablated plasma levels of particular peptides synthesized in the GCT after sialoadenectomy of mice (Sheffield and Welsch, 1987; Tsutsumi et al., 1986; Kurachi and Oka, 1985) , and other more direct data show that peptides of GCT origin, including renin, are released from salivary glands into the circulation (Aloe et al., 1986; Menzie et al., 1974) . The apparent secretion of renin and kallikrein from the basolateral surface of GCT cells adjacent to fenestrated capillaries (Figure 4) shows the probable route by which these peptides are released into the circulation. Kallikrein-containing granules are also released into the lumen of the GCT (Hazen-Martin and Simson, 1986) . Some GCT granules contain both renin and EGF ( h a k a et al., 1981) and most contain kallikrein (Figure 4) . The kallikrein may be present as a processing protease for the other peptides within the granule, as both EGF and prorenin are substrates for one particular GCT kallikrein (Kim et al., 1991) . Other EGF-and NGF-processing proteases are also among the 11 kallikreins synthesized in the GCT Evans and Richards, 1985) .
In conclusion, these data show in mice that glandular kallikreins and renin can be secreted from basolateral as well as apical surfaces of the duct cells in which they are synthesized. In humans, secretion of renal/pancreatic kallikrein by this route and clearance by the kidneys could interfere with the interpretation of urinary kallikrein measurements.
